Vascular dementia: Pharmacological treatment approaches and perspectives

References

• AnnerstedtLElmstahlSIngvadB2000Family caregiving in dementia-an analysis of the caregiver’s burden and the “breaking point” when home care becomes inadequateScand J Public Health28233110817311
   PubMed Web of Science ®Google Scholar
• AreosaSASherriffFMcShaneR2005Memantine for dementiaCochrane Database Syst Rev, C Info:CD003154
   Google Scholar
• BaskysABlaabjergM2005Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategiesJ Neurol Sci229230201–9
   Web of Science ®Google Scholar
• BroichK2003Regulatory Issues in Vascular DementiaInternational Psychogriatrics15suppl 1297301
   Web of Science ®Google Scholar
• BuddSL1998Mechanisms of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulationPharmacol Ther80203299839772
   PubMed Web of Science ®Google Scholar
• BullockRErkinjunttiTLilienfeldS2004Management of Patients with Alzheimer’s Disease plus Cerebrovascular Disease: 12-Month Treatment with GalantamineDement Geriatr Cogn Disord17293414560062
   PubMed Web of Science ®Google Scholar
• ChoiDWRothmanSM1990The role of glutamate neurotoxicity in hypoxic ischemic neuronal deathAnnu Rev Neurosci13171821970230
   PubMed Web of Science ®Google Scholar
• CoyleJTPuttfarkenP1993Oxidative stress, glutamate, and neurodegenerative disordersScience262689957901908
   PubMed Web of Science ®Google Scholar
• CraigDBirksJ2006Galantamine for vascular cognitive impairmentCochrane Database Syst Rev1CD00474616437493
   PubMedGoogle Scholar
• EndresMNamuraSShimizu-Sasamata1998Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of caspase familyJ Cereb Blood Flow Metab18238479498840
   PubMed Web of Science ®Google Scholar
• FeilN1992Validation therapyGeriatr Nurs13129331319934
   PubMedGoogle Scholar
• FrancisP2006Targeting Cell Death in DementiaAlzheimer Dis Assoc Disord20suppl 1S3S716772754
   PubMed Web of Science ®Google Scholar
• FioravantiMYanagiM2005Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyCochrane Database Syst Rev2CD00026915846601
   PubMedGoogle Scholar
• GladstoneDJBlackSEHakimAM2002Toward wisdom from failure: Lessons from neuroprotective stroke trials and new therapeutic directionsStroke3321233612154275
   PubMed Web of Science ®Google Scholar
• GrovesWCBrandtJSteinbergM2000Vascular dementia and alzheimer’s disease: Is there a difference? A comparison of symptoms by disease durationJ Neuropsychiatry Clin Neurosci123051510956564
   PubMed Web of Science ®Google Scholar
• HenriksenALSt DennisCSetterSM2006Dementia with lewy bodies: therapeutic opportunities and pitfallsConsult Pharm2156175
   Google Scholar
• HerrmannWMStephanKGaedeK1997A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementiaDement Geriatr Cogn Disord89178997547
   PubMed Web of Science ®Google Scholar
• KalariaRN2003Comparison between Alzheimer’s disease and vascular dementia: implications for treatmentNeurol Res25661414503021
   PubMed Web of Science ®Google Scholar
• KoontzJBaskysA2005Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: A double-blind placebo-controlled studyAm J Alzheimers Dis Other Demen2029530216273995
   PubMedGoogle Scholar
• LiptonSAChenH-SV2004Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantineCell Death and Differentiation111820
   Web of Science ®Google Scholar
• LiptonSA2004Failures and Successes of NMDA Receptor Antagonists: Molecular Basis for the Use of Open-Channel Blockers like Memantine in the Treatment of Acute and Chronic Neurologic InsultsNeuroRx11011015717010
   PubMedGoogle Scholar
• LyketosCGSteinbergMTschanzJT2000Mental and behavioral disturbances in dementia: Findings from the Cache County studyAm J Psychiatry1577081410784462
   PubMed Web of Science ®Google Scholar
• MacDonaldJFWojtowiczJMBaskysA1996Excitatory synaptic transmissionBaskysARemingtonGBrain mechanisms and psychotropic drugsCRC PressBoca Raton
   Google Scholar
• MaloufRBirksJ2004Donepezil for vascular cognitive impairmentCochrane Database Syst Rev1CD00439514974068
   PubMedGoogle Scholar
• MartinLJAl-AbdullaNABrambrinkAM1998Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosisBrain Res Bull462813099671259
   PubMed Web of Science ®Google Scholar
• McGuinnessBToddSPassmoreP2006Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaCochrane Database Syst Rev2CD00403416625595
   PubMedGoogle Scholar
• MicieliG2006Vascular dementiaNeurol Sci27S37S3916708182
   PubMed Web of Science ®Google Scholar
• MorettiRTorrePAntonelloRM2002Rivastigmine in subcortical vascular dementia: An open 22-month studyJ Neurol Sci203–204C1416
   Web of Science ®Google Scholar
• MuirKWLeesKR1995Clinical experience with excitatory amino acid antagonist drugsStroke26503137886734
   PubMed Web of Science ®Google Scholar
• NitatoriTSatoNWaguriS1995Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosisJ Neurosci151001117869078
   PubMed Web of Science ®Google Scholar
• OlinJSchneiderLNovitA2000Hydergine for dementiaCochrane Database Syst Rev3CD00035910796534
   PubMedGoogle Scholar
• OlneyJW1969Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamateScience164719215778021
   PubMed Web of Science ®Google Scholar
• OrgogozoJMRigaudASStofflerA2002Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)Stroke331834912105362
   PubMed Web of Science ®Google Scholar
• PantoniL2004Treatment of vascular dementia: evidence from trials with non-cholinergic drugsJ Neurol Sci226677015537523
   PubMed Web of Science ®Google Scholar
• Portera-CailliauCPriceDLMartinLJ1997Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuumJ Comp Neurol37870879120055
   PubMed Web of Science ®Google Scholar
• ReynoldsEH2002Benefits and risks of folic acid to the nervous systemJ Neurol Neurosurg Psychiatr725677111971038
   PubMed Web of Science ®Google Scholar
• RomanGC2002Vascular dementia revisited: Diagnosis, pathogenesis, treatment, and preventionMed Clin N Am864779912168556
   PubMed Web of Science ®Google Scholar
• RomanGCWilkinsonDGDoodyRS2005Donepezil in vascular dementia: combined analysis of two large-scale clinical trialsDement Geriatr Cogn Disord203384416192723
   PubMed Web of Science ®Google Scholar
• SaletuBPaulusELinzmayerL1995Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping studyPsychopharmacology (Berl)117385957604138
   PubMed Web of Science ®Google Scholar
• SchindlerRJ2005Dementia with cerebrovascular disease: the benefits of early treatmentEuropean Journal of Neurology12s3172116144533
   PubMed Web of Science ®Google Scholar
• SloviterRS2002Apoptosis: a guide for the perplexedTrends Pharmacol Sci23192411804647
   PubMed Web of Science ®Google Scholar
• SmithMWellsJBorrieM2006Treatment Effect Size of Memantine Therapy in Alzheimer Disease and Vascular DementiaAlzheimer Dis Assoc Disord20133716917181
   PubMed Web of Science ®Google Scholar
• VetterPHKraussSSteinerO1999Vascular dementia versus dementia of Alzheimer’s type: do they have differential effects on caregivers’ burden?J Gerontol Ser B: Psychol Sci Soc Sci542S938
   Google Scholar
• VincentSLaneR2003Rivastigmine in Vascular DementiaInt Psycho-geriatr15s12015
   Web of Science ®Google Scholar
• WallinA2003Classification and Subtypes of Vascular DementiaInt Psychogeriatr15s1273716191214
   PubMed Web of Science ®Google Scholar
• WilcockGMobiusHJStofflerA2002A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)Int Clin Psychopharmacol729730512409683
   PubMed Web of Science ®Google Scholar
• ZesiewiczTABakerMJDunnePB2001Diffuse Lewy Body DiseaseCurr Treat Options Neurol35071811581527
   PubMedGoogle Scholar